David Wildes

7PUBLICATIONS
90CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 24, 2025
A neomorphic protein interface catalyzes covalent inhibition of RASG12D aspartic acid in tumors.

Caroline Weller, G Leslie Burnett, Lingyan Jiang

|Nov 12, 2024
Author Correction: Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer.

Urszula N Wasko, Jingjing Jiang, Tanner C Dalton

|Jul 18, 2024
Combined inhibition of KRASG12C and mTORC1 kinase is synergistic in non-small cell lung cancer.

Hidenori Kitai, Philip H Choi, Yu C Yang

|Apr 09, 2024
Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven Cancers.

Jingjing Jiang, Lingyan Jiang, Benjamin J Maldonato

|Apr 08, 2024
Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy.

Matthew Holderfield, Bianca J Lee, Jingjing Jiang

Pageof 2